Source:http://linkedlifedata.com/resource/pubmed/id/17632790
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
2007-7-31
|
pubmed:abstractText |
Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by progressive neurodegeneration, immunodeficiency, susceptibility to cancer, genomic instability, and sensitivity to ionizing radiation. A-T is caused by mutations that eliminate or inactivate the nuclear protein kinase ATM, the chief activator of the cellular response to double strand breaks (DSBs) in the DNA. Mild A-T is usually caused by ATM mutations that leave residual amounts of active ATM. We studied two siblings with mild A-T, as defined by clinical examination and a quantitative A-T neurological index. Surprisingly, no ATM was detected in the patients' cells, and sequence analysis revealed that they were homozygous for a truncating ATM mutation (5653delA) that is expected to lead to the classical, severe neurological presentation. Moreover, the cellular phenotype of these patients was indistinguishable from that of classical A-T: all the tested parameters of the DSB response were severely defective as in typical A-T. This analysis shows that the severity of the neurological component of A-T is determined not only by ATM mutations but also by other influences yet to be found.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ataxia telangiectasia mutated...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1552-4825
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
143A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1827-34
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:17632790-Ataxia Telangiectasia,
pubmed-meshheading:17632790-Brain,
pubmed-meshheading:17632790-Cell Cycle Proteins,
pubmed-meshheading:17632790-Child,
pubmed-meshheading:17632790-DNA-Binding Proteins,
pubmed-meshheading:17632790-Humans,
pubmed-meshheading:17632790-Magnetic Resonance Imaging,
pubmed-meshheading:17632790-Male,
pubmed-meshheading:17632790-Models, Genetic,
pubmed-meshheading:17632790-Mutation,
pubmed-meshheading:17632790-Pedigree,
pubmed-meshheading:17632790-Phenotype,
pubmed-meshheading:17632790-Protein-Serine-Threonine Kinases,
pubmed-meshheading:17632790-Tumor Suppressor Proteins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
|
pubmed:affiliation |
The David and Inez Myers Laboratory for Genetic Research, Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|